Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using Discrete Choice Experiment for Antiepileptic Drugs

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1231
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Patient Preferences for Asthma Therapy: A Discrete Choice Experiment

Primary Care Respiratory Journal
2007English

Using Discrete Choice Experiment to Elicit Patient Preferences for Osteoporosis Drug Treatments: Where to From Here?

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Patient and Physician Preferences for Treating Adjuvant Melanoma: A Discrete Choice Experiment

Journal of Cancer Therapy
2017English

Societal Preferences for Funding Orphan Drugs in the UK: An Application of Value Based Pricing Using Discrete Choice Experiment Methods

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

A Discrete Choice Experiment Investigating Preferences for Funding Drugs Used to Treat Orphan Diseases: An Exploratory Study

Health Economics, Policy and Law
Health Policy
2010English

Patient Preferences for Nutritional Supplementation to Improve Fracture Healing: A Discrete Choice Experiment

BMJ Open
Medicine
2018English

PSY42 Chronic Pain: Patient Treatment Preferences - A Discrete Choice Experiment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Education and Patient Preferences for Treating Type 2 Diabetes: A Stratified Discrete-Choice Experiment

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy